Top Markets
Coin of the day
Eastgate Biotech Corp. Eastgate Biotech Corp.

Eastgate Biotech Corp.

ETBI
Classifica tra le azioni #34128
EastGate Biotech Corp. is a pharmaceutical company specializing in the... EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
Prezzo delle azioni
$0.003
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$6.17M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-25.00%
Paese
CA
Scambia Eastgate Biotech Corp. (ETBI)

Categoria

EPS per Eastgate Biotech Corp. (ETBI)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Eastgate Biotech Corp., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Eastgate Biotech Corp. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti